American Healthcare
AHR

American Healthcare (AHR) analyst forecast and price target

Recent analyst ratings

FirmActionRatingPrice targetDate
BarclaysMaintainedOverweight$66.00 from $61.00Aug 31, 2026
KeybancMaintainedOverweight$68.00 from $58.00Aug 19, 2026
RBC CapitalMaintainedOutperform$61.00 from $56.00Aug 14, 2026
Truist SecuritiesMaintainedBuy$61.00 from $57.00Aug 14, 2026
CitigroupMaintainedBuy$65.00 from $55.00Aug 13, 2026
CitizensMaintainedMarket Outperform$65.00 from $60.00Jul 27, 2026
Compass PointInitiated CoverageBuy$70.00Jul 21, 2026
UBSMaintainedBuy$63.00 from $60.00Jul 8, 2026
BarclaysInitiated CoverageOverweight$61.00Jul 7, 2026
CitigroupUpgradedNeutral → Buy$55.00Jun 23, 2026
ScotiabankMaintainedSector Outperform$51.00 from $59.00Jun 18, 2026
KeybancMaintainedOverweight$58.00 from $55.00May 28, 2026
RBC CapitalMaintainedOutperform$56.00 from $54.00May 26, 2026
Truist SecuritiesMaintainedBuy$57.00 from $52.00Mar 13, 2026
ScotiabankMaintainedSector Outperform$59.00 from $55.00Mar 11, 2026
CitigroupMaintainedNeutral$55.00 from $52.00Mar 2, 2026
CitizensMaintainedMarket Outperform$60.00Feb 5, 2026
BMO CapitalInitiated CoverageOutperform$55.00Jan 29, 2026
Truist SecuritiesMaintainedBuy$52.00 from $53.00Jan 20, 2026
Truist SecuritiesMaintainedBuy$53.00 from $46.00Nov 26, 2025

Frequently asked questions

  • What is the latest analyst rating on AHR?

    On Aug 31, 2026, Barclays maintained American Healthcare at Overweight with a price target of $66.00.

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.